"The FDA PMA submission is a major milestone – our first regulatory approval application for our AI-enabled wide-field OCT technology, as well as for a specific indication label," said Perimeter ...

TORONTO and DALLAS, March 17, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced ...

Perimeter Medical Imaging AI (PYNKF) announced the submission of a Premarket Approval application to the U.S ... to support the Company’s FDA PMA for B-Series OCT with ImgAssist AI 2.0 for ...

NVNO boasts a market capitalization of 59.8 million. The company is estimated to report 31.9% earnings growth in 2024. Positioning enVVeno for Growth in the Bioprosthetic Market VenoValve’s PMA ...

a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, ...

is pleased to announce that the FDA has accepted Module 1 of the company's premarket approval (PMA) application, and that this module is now considered closed. Module 1 contained the quality ...